Related Experiment Video
Updated: Apr 27, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
[Update on current care guideline: atrial fibrillation]
Insights
Atrial fibrillation (AF) is rising, requiring prompt anticoagulation for stroke prevention. Treatment choices involve balancing risks and benefits of warfarin versus novel oral anticoagulants for patients with permanent AF.
Area of Science:
- Cardiology
- Pharmacology
- Public Health
Context:
- Increasing global prevalence and incidence of atrial fibrillation (AF).
- Growing need for effective thromboembolic complication management strategies.
- Evolving therapeutic landscape for AF treatment.
Purpose:
- To outline current key recommendations for atrial fibrillation management.
- To guide the selection of anticoagulation therapy in AF patients.
- To emphasize individualized treatment approaches based on patient risk.
Summary:
- Management of atrial fibrillation (AF) involves prompt oral anticoagulation for high-thromboembolic risk patients.
- Antiarrhythmic drugs and invasive therapies are indicated for symptomatic AF.
- Rate control is crucial for permanent AF, with careful selection between warfarin and novel oral anticoagulants (apixaban, dabigatran, rivaroxaban).
Impact:
- Improved patient outcomes through timely and appropriate AF management.
- Reduced incidence of stroke and other thromboembolic events in AF patients.
- Optimized pharmacotherapy selection for atrial fibrillation based on risk-benefit analysis.
Abstract:
The prevalence and incidence of atrial fibrillation (AF) are increasing rapidly. Key recommendations in management of AF include prompt administration of oral anticoagulation to all patients with elevated risk of thromboembolic complications, proper use of antiarrhythmic drugs and invasive therapies in highly symptomatic patients and adequate rate control in patients with permanent AF. The selection between warfarin and the novel oral anticoagulants (apixaban, dabigatran, rivaroxaban) is based on careful evaluation of the benefits and disadvantages of the drugs in a given patient.
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
Cardiac Catheterization IV: Nursing Management
Aortic Regurgitation IV: Nursing Management
Acute Coronary Syndrome V: Nursing Management
Dysrhythmias VII: Nursing Management of Dysrhythmias
Dysrhythmias VI: Management of Dysrhythmias

